UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Improved outcome in 445 patients with Wegener's granulomatosis in a German vasculitis center over four decades

Arthritis & rheumatology (Hoboken, N.J.), 2011-01, Vol.63 (1), p.257-266

2011

Volltextzugriff (PDF)

Myeloperoxidase–Antineutrophil Cytoplasmic Antibody (ANCA)–Positive Granulomatosis With Polyangiitis (Wegener's) Is a Clinically Distinct Subset of ANCA‐Associated Vasculitis: A Retrospective Analysis of 315 Patients From a German Vasculitis Referral Center

Arthritis & rheumatology (Hoboken, N.J.), 2016-12, Vol.68 (12), p.2953-2963

2016

Volltextzugriff (PDF)

Stable incidence of primary systemic vasculitides over five years: Results from the German vasculitis register

Arthritis and rheumatism, 2005-02, Vol.53 (1), p.93-99

2005

Volltextzugriff (PDF)

Diagnostics and therapy of antineutrophil cytoplasmic antibody (ANCA) associated vasculitides

Current pharmaceutical design, 2012, Vol.18 (29), p.4537-4541

Reinhold-Keller, Eva

2012

Volltextzugriff (PDF)

Doubled prevalence rates of ANCA-associated vasculitides and giant cell arteritis between 1994 and 2006 in northern Germany

Rheumatology (Oxford, England), 2014-05, Vol.53 (5), p.882-889

2014

Volltextzugriff (PDF)

S1-Leitlinie Diagnostik und Therapie der ANCA-assoziierten Vaskulitiden

Zeitschrift für Rheumatologie, 2017-12, Vol.76 (Suppl 3), p.77-104

2017

Volltextzugriff (PDF)

Necrotizing parotitis: An unusual initial manifestation of Wegener’s granulomatosis

Otolaryngology-head and neck surgery, 2006-09, Vol.135 (3), p.485-486

2006

Volltextzugriff (PDF)

High rate of renal relapse in 71 patients with Wegener's granulomatosis under maintenance of remission with low‐dose methotrexate

Arthritis and rheumatism, 2002-06, Vol.47 (3), p.326-332

2002

Volltextzugriff (PDF)

Rituximab for refractory granulomatosis with polyangiitis (Wegener's granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations

Annals of the rheumatic diseases, 2012-03, Vol.71 (3), p.327-333

2012

Volltextzugriff (PDF)

Prospective long-term follow-up of patients with localised Wegener's granulomatosis: does it occur as persistent disease stage?

Annals of the rheumatic diseases, 2010-11, Vol.69 (11), p.1934-1939

2010

Volltextzugriff (PDF)

Clinical presentation and long-term outcome of 144 patients with microscopic polyangiitis in a monocentric German cohort

Rheumatology (Oxford, England), 2016-01, Vol.55 (1), p.71-79

2016

Volltextzugriff (PDF)

Effect of Wegener's granulomatosis on work disability, need for medical care, and quality of life in patients younger than 40 years at diagnosis

Arthritis and rheumatism, 2002-06, Vol.47 (3), p.320-325

2002

Volltextzugriff (PDF)

An interdisciplinary approach to the care of patients with Wegener's granulomatosis: Long‐term outcome in 155 patients

Arthritis and rheumatism, 2000-05, Vol.43 (5), p.1021-1032

2000

Volltextzugriff (PDF)

Wegenersche Granulomatose

Aktuelle Rheumatologie, 2008-04, Vol.33 (2), p.78-89

2008

Volltextzugriff (PDF)

S1 guidelines Diagnostics and treatment of ANCA-associated vasculitis

Zeitschrift für Rheumatologie, 2017-11, Vol.76 (Suppl 3), p.77-104

2017

Volltextzugriff (PDF)

Symmetrische Polyarthritis bei einem Patienten mit Churg-Strauss-Syndrom

Deutsche medizinische Wochenschrift, 2005-08, Vol.130 (33), p.1871-1873

2005

Volltextzugriff (PDF)

Differenzialdiagnose akraler Schmerzen: Junger Mann mit akralen Schmerzen, Fieberschüben und Hörverlust

Aktuelle Rheumatologie, 2009-04, Vol.34 (2), p.126-131

2009

Volltextzugriff (PDF)

Stable incidence of systemic vasculitides in schleswig-holstein, Germany

Deutsches Ärzteblatt international, 2008-05, Vol.105 (19), p.355-361

2008

Volltextzugriff (PDF)

Predicting mortality in systemic Wegener's granulomatosis: Comment on the article by Bligny et al

Arthritis and rheumatism, 2004-10, Vol.51 (5), p.868-869

2004

Volltextzugriff (PDF)

Induction of remission in Wegener's granulomatosis with low dose methotrexate

Journal of rheumatology, 1998-03, Vol.25 (3), p.492

1998

Volltextzugriff (PDF)

Maintaining remission in granulomatosis with polyangiitis (Wegener s)

International journal of clinical rheumatology, 2012-10, Vol.7 (5), p.479-488

2012

Volltextzugriff (PDF)

Stable Incidence of Systemic Vasculitides in Schleswig-Holstein, Germany

Deutsches Ärzteblatt international, 2008-05

2008

Volltextzugriff (PDF)

Heterogeneity of CD4 and CD8+ memory T cells in localized and generalized Wegener's granulomatosis

Arthritis research & therapy, 2003-01, Vol.5 (1), p.R25-R31, Article R25

2003

Volltextzugriff (PDF)

How long should cyclophosphamide therapy of Wegener's granulomatosis continue?

Deutsche medizinische Wochenschrift, 2002-09, Vol.127 (37), p.1909

Reinhold-Keller, Eva

2002

Volltextzugriff (PDF)

Elevated procalcitonin levels in active Wegener's granulomatosis

Journal of rheumatology, 1998-08, Vol.25 (8), p.1531

1998

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(43)

Sprache

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Improved outcome in 445 patients with Wegener's granulomatosis in a German vasculitis center over four decades

Myeloperoxidase–Antineutrophil Cytoplasmic Antibody (ANCA)–Positive Granulomatosis With Polyangiitis (Wegener's) Is a Clinically Distinct Subset of ANCA‐Associated Vasculitis: A Retrospective Analysis of 315 Patients From a German Vasculitis Referral Center

Stable incidence of primary systemic vasculitides over five years: Results from the German vasculitis register

Diagnostics and therapy of antineutrophil cytoplasmic antibody (ANCA) associated vasculitides

Doubled prevalence rates of ANCA-associated vasculitides and giant cell arteritis between 1994 and 2006 in northern Germany

S1-Leitlinie Diagnostik und Therapie der ANCA-assoziierten Vaskulitiden

Necrotizing parotitis: An unusual initial manifestation of Wegener’s granulomatosis

High rate of renal relapse in 71 patients with Wegener's granulomatosis under maintenance of remission with low‐dose methotrexate

Rituximab for refractory granulomatosis with polyangiitis (Wegener's granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations

Prospective long-term follow-up of patients with localised Wegener's granulomatosis: does it occur as persistent disease stage?

Clinical presentation and long-term outcome of 144 patients with microscopic polyangiitis in a monocentric German cohort

Effect of Wegener's granulomatosis on work disability, need for medical care, and quality of life in patients younger than 40 years at diagnosis

An interdisciplinary approach to the care of patients with Wegener's granulomatosis: Long‐term outcome in 155 patients

Wegenersche Granulomatose

S1 guidelines Diagnostics and treatment of ANCA-associated vasculitis

Symmetrische Polyarthritis bei einem Patienten mit Churg-Strauss-Syndrom

Differenzialdiagnose akraler Schmerzen: Junger Mann mit akralen Schmerzen, Fieberschüben und Hörverlust

Stable incidence of systemic vasculitides in schleswig-holstein, Germany

Predicting mortality in systemic Wegener's granulomatosis: Comment on the article by Bligny et al

Induction of remission in Wegener's granulomatosis with low dose methotrexate

Maintaining remission in granulomatosis with polyangiitis (Wegener s)

Stable Incidence of Systemic Vasculitides in Schleswig-Holstein, Germany

Heterogeneity of CD4 and CD8+ memory T cells in localized and generalized Wegener's granulomatosis

How long should cyclophosphamide therapy of Wegener's granulomatosis continue?

Elevated procalcitonin levels in active Wegener's granulomatosis

Suchergebnisse filtern